137 related articles for article (PubMed ID: 15337227)
1. Fibroblast growth factor-1 improves cardiac functional recovery and enhances cell survival after ischemia and reperfusion: a fibroblast growth factor receptor, protein kinase C, and tyrosine kinase-dependent mechanism.
Palmen M; Daemen MJ; De Windt LJ; Willems J; Dassen WR; Heeneman S; Zimmermann R; Van Bilsen M; Doevendans PA
J Am Coll Cardiol; 2004 Sep; 44(5):1113-23. PubMed ID: 15337227
[TBL] [Abstract][Full Text] [Related]
2. FGF-2-induced negative inotropism and cardioprotection are inhibited by chelerythrine: involvement of sarcolemmal calcium-independent protein kinase C.
Padua RR; Merle PL; Doble BW; Yu CH; Zahradka P; Pierce GN; Panagia V; Kardami E
J Mol Cell Cardiol; 1998 Dec; 30(12):2695-709. PubMed ID: 9990540
[TBL] [Abstract][Full Text] [Related]
3. Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia.
House SL; Bolte C; Zhou M; Doetschman T; Klevitsky R; Newman G; Schultz Jel J
Circulation; 2003 Dec; 108(25):3140-8. PubMed ID: 14656920
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of protein kinase C alpha improves myocardial beta-adrenergic receptor signaling and ventricular function in a model of myocardial preservation.
D'Souza KM; Petrashevskaya NN; Merrill WH; Akhter SA
J Thorac Cardiovasc Surg; 2008 Jan; 135(1):172-9, 179.e1. PubMed ID: 18179937
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor-1 prevents myocardial apoptosis triggered by ischemia reperfusion injury.
Cuevas P; Reimers D; Carceller F; Martinez-Coso V; Redondo-Horcajo M; Saenz de Tejada I; Giménez-Gallego G
Eur J Med Res; 1997 Nov; 2(11):465-8. PubMed ID: 9385115
[TBL] [Abstract][Full Text] [Related]
6. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy.
Ishibe T; Nakayama T; Okamoto T; Aoyama T; Nishijo K; Shibata KR; Shima Y; Nagayama S; Katagiri T; Nakamura Y; Nakamura T; Toguchida J
Clin Cancer Res; 2005 Apr; 11(7):2702-12. PubMed ID: 15814652
[TBL] [Abstract][Full Text] [Related]
7. Dependence of delta1-opioid receptor-induced cardioprotection on a tyrosine kinase-dependent but not a Src-dependent pathway.
Fryer RM; Wang Y; Hsu AK; Nagase H; Gross GJ
J Pharmacol Exp Ther; 2001 Nov; 299(2):477-82. PubMed ID: 11602657
[TBL] [Abstract][Full Text] [Related]
8. Myocardial recovery after ischemia and reperfusion injury is significantly impaired in hearts with transgenic overexpression of beta-adrenergic receptor kinase.
Chen EP; Bittner HB; Akhter SA; Koch WJ; Davis RD
Circulation; 1998 Nov; 98(19 Suppl):II249-53; discussion II253-4. PubMed ID: 9852910
[TBL] [Abstract][Full Text] [Related]
9. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
[TBL] [Abstract][Full Text] [Related]
10. Post-conditioning induced cardioprotection requires signaling through a redox-sensitive mechanism, mitochondrial ATP-sensitive K+ channel and protein kinase C activation.
Penna C; Rastaldo R; Mancardi D; Raimondo S; Cappello S; Gattullo D; Losano G; Pagliaro P
Basic Res Cardiol; 2006 Mar; 101(2):180-9. PubMed ID: 16450075
[TBL] [Abstract][Full Text] [Related]
11. High molecular weight FGF-2 promotes postconditioning-like cardioprotection linked to activation of protein kinase C isoforms, as well as Akt and p70 S6 kinases. [corrected].
Jiang ZS; Wen GB; Tang ZH; Srisakuldee W; Fandrich RR; Kardami E
Can J Physiol Pharmacol; 2009 Oct; 87(10):798-804. PubMed ID: 19898562
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of angiogenesis: experimental models define cellular trafficking of FGF-1.
Hicks KK; Shin JT; Opalenik SR; Thompson JA
P R Health Sci J; 1996 Sep; 15(3):179-86. PubMed ID: 8994282
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of connexin-43 at serine 262 promotes a cardiac injury-resistant state.
Srisakuldee W; Jeyaraman MM; Nickel BE; Tanguy S; Jiang ZS; Kardami E
Cardiovasc Res; 2009 Sep; 83(4):672-81. PubMed ID: 19423616
[TBL] [Abstract][Full Text] [Related]
14. Different abilities of the four FGFRs to mediate FGF-1 translocation are linked to differences in the receptor C-terminal tail.
Sørensen V; Wiedlocha A; Haugsten EM; Khnykin D; Wesche J; Olsnes S
J Cell Sci; 2006 Oct; 119(Pt 20):4332-41. PubMed ID: 17003104
[TBL] [Abstract][Full Text] [Related]
15. Cardiospecific overexpression of the prostaglandin EP3 receptor attenuates ischemia-induced myocardial injury.
Martin M; Meyer-Kirchrath J; Kaber G; Jacoby C; Flögel U; Schrader J; Rüther U; Schrör K; Hohlfeld T
Circulation; 2005 Jul; 112(3):400-6. PubMed ID: 16009796
[TBL] [Abstract][Full Text] [Related]
16. Concomitant downregulation of proliferation/survival pathways dependent on FGF-R3, JAK2 and BCMA in human multiple myeloma cells by multi-kinase targeting.
Cassinelli G; Ronchetti D; Laccabue D; Mattioli M; Cuccuru G; Favini E; Nicolini V; Greco A; Neri A; Zunino F; Lanzi C
Biochem Pharmacol; 2009 Nov; 78(9):1139-47. PubMed ID: 19555670
[TBL] [Abstract][Full Text] [Related]
17. Acute protection of ischemic heart by FGF-2: involvement of FGF-2 receptors and protein kinase C.
Jiang ZS; Padua RR; Ju H; Doble BW; Jin Y; Hao J; Cattini PA; Dixon IM; Kardami E
Am J Physiol Heart Circ Physiol; 2002 Mar; 282(3):H1071-80. PubMed ID: 11834506
[TBL] [Abstract][Full Text] [Related]
18. Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway.
Zhu M; Feng J; Lucchinetti E; Fischer G; Xu L; Pedrazzini T; Schaub MC; Zaugg M
Cardiovasc Res; 2006 Oct; 72(1):152-62. PubMed ID: 16901477
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular protection of nonmitogenic human acidic fibroblast growth factor from oxidative damage in vitro and in vivo.
Li XK; Lin ZF; Li Y; Hu S; Tan Y; Huang Z; Meng J; Liang LM; Xiao J; Qu J; Cai L
Cardiovasc Pathol; 2007; 16(2):85-91. PubMed ID: 17317541
[TBL] [Abstract][Full Text] [Related]
20. HB-EGF enhances restitution after intestinal ischemia/reperfusion via PI3K/Akt and MEK/ERK1/2 activation.
El-Assal ON; Besner GE
Gastroenterology; 2005 Aug; 129(2):609-25. PubMed ID: 16083716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
